Sei Investments Co. Sells 1,218 Shares of Mettler-Toledo International Inc. (NYSE:MTD)

Sei Investments Co. reduced its holdings in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 5.0% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 23,202 shares of the medical instruments supplier’s stock after selling 1,218 shares during the quarter. Sei Investments Co. owned approximately 0.11% of Mettler-Toledo International worth $32,432,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. EverSource Wealth Advisors LLC grew its position in Mettler-Toledo International by 8.0% in the first quarter. EverSource Wealth Advisors LLC now owns 95 shares of the medical instruments supplier’s stock valued at $117,000 after purchasing an additional 7 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Mettler-Toledo International by 6.6% during the 2nd quarter. UMB Bank n.a. now owns 113 shares of the medical instruments supplier’s stock worth $158,000 after buying an additional 7 shares during the last quarter. Gulf International Bank UK Ltd grew its holdings in shares of Mettler-Toledo International by 0.4% in the 1st quarter. Gulf International Bank UK Ltd now owns 1,813 shares of the medical instruments supplier’s stock valued at $2,413,000 after acquiring an additional 8 shares in the last quarter. Bellevue Group AG increased its position in shares of Mettler-Toledo International by 32.0% in the first quarter. Bellevue Group AG now owns 33 shares of the medical instruments supplier’s stock valued at $44,000 after acquiring an additional 8 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV raised its holdings in Mettler-Toledo International by 7.2% during the second quarter. Massmutual Trust Co. FSB ADV now owns 119 shares of the medical instruments supplier’s stock worth $166,000 after acquiring an additional 8 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CFO Shawn Vadala sold 250 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the sale, the chief financial officer now owns 4,914 shares of the company’s stock, valued at $6,884,514. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, CFO Shawn Vadala sold 250 shares of the company’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total value of $350,250.00. Following the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at approximately $6,884,514. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Christian Magloth sold 1,000 shares of Mettler-Toledo International stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the transaction, the insider now directly owns 734 shares of the company’s stock, valued at approximately $1,044,459.98. The disclosure for this sale can be found here. 1.94% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms have weighed in on MTD. JPMorgan Chase & Co. raised their price target on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Stifel Nicolaus upped their price objective on Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a “buy” rating in a research note on Monday, August 5th. Wells Fargo & Company initiated coverage on Mettler-Toledo International in a research report on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 price objective for the company. StockNews.com raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. Finally, Evercore ISI increased their price objective on Mettler-Toledo International from $1,375.00 to $1,390.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 2nd. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $1,356.25.

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,405.90 on Tuesday. The stock has a fifty day moving average of $1,409.58 and a 200-day moving average of $1,376.57. Mettler-Toledo International Inc. has a 52 week low of $928.49 and a 52 week high of $1,546.93. The stock has a market capitalization of $30.03 billion, a price-to-earnings ratio of 39.43, a PEG ratio of 3.70 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share for the quarter, topping analysts’ consensus estimates of $9.00 by $0.65. The firm had revenue of $946.75 million for the quarter, compared to analyst estimates of $929.13 million. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 575.61%. The company’s revenue for the quarter was down 3.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $10.19 EPS. As a group, equities analysts forecast that Mettler-Toledo International Inc. will post 40.35 EPS for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.